President Donald Trump gave American drug companies an ultimatum last month.
Either they agree to adopt foreign-style price controls, or the administration “will deploy every tool in [its] arsenal” to do it for them.
More specifically, the president asked drug firms to base U.S. drug prices for a given drug on the lowest price offered elsewhere in the developed world — a policy known as “most favored nation,” or MFN, pricing.
Read more at Newsmax© 2025 Newsmax. All rights reserved.